Author

Y. Kim

Institutions: Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam

Observed institutions: University of California, Los Angeles, Chonnam National University Hwasun Hospital, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam

OpenAlex ID: A5087930899

FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC

2021 · R. Herbst, F. De Marinis, et al. · Journal of Thoracic Oncology · 11

P2.03-058 Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC)

2017 · J.C. Yang, K. Reckamp, et al. · Journal of Thoracic Oncology · 3

P018 Afatinib Named Patient Use Program in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers

2018 · G. Chang, D.C. Lam, et al. · Journal of Thoracic Oncology · 2

PL02.05 IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

2021 · N. Altorki, E. Felip, et al. · Journal of Thoracic Oncology · 1

2781P Prognostic and predictive value of CD8 intratumoral density in relation to transcriptional subtype and spatial transcriptomics in SCLC

2025 · S. Elings, D. Naves, et al. · Annals of Oncology

P1.11-13 Noninvasive Detection of Early Stage NSCLC EGFR Mutations Using Electric Field Induced Release and Measurement (EFIRM)

2018 · F. Wei, C. Strom, et al. · Journal of Thoracic Oncology

In reply: Treatment of cachexia: An overview of recent developments

2015 · Manoch Rattanasompattikul, Ramanath Dukkipati, et al.

Works count: 7

Citation count: 17

H-index: 2

I10-index: 1